STML has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STML has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stemline Therapeutics's Free Cash Flow for the three months ended in Mar. 2020 was $-13.79 Mil. Stemline Therapeutics's Revenue for the three months ended in Mar. 2020 was $8.87 Mil. Therefore, Stemline Therapeutics's FCF Margin % for the quarter that ended in Mar. 2020 was -155.39%.
As of today, Stemline Therapeutics's current FCF Yield % is 0.00%.
The historical rank and industry rank for Stemline Therapeutics's FCF Margin % or its related term are showing as below:
The historical data trend for Stemline Therapeutics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stemline Therapeutics Annual Data | |||||||||||||||||||||
Trend | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | |||||||||||
FCF Margin % | Get a 7-Day Free Trial | - | - | - | - | -156.77 |
Stemline Therapeutics Quarterly Data | ||||||||||||||||||||
Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | |
FCF Margin % | Get a 7-Day Free Trial | -439.91 | -162.89 | -98.78 | -94.65 | -155.39 |
For the Biotechnology subindustry, Stemline Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Stemline Therapeutics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Stemline Therapeutics's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Stemline Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2019 is calculated as
FCF Margin | = | Free Cash Flow (A: Dec. 2019 ) | / | Revenue (A: Dec. 2019 ) |
= | -67.753 | / | 43.217 | |
= | -156.77 % |
Stemline Therapeutics's FCF Margin for the quarter that ended in Mar. 2020 is calculated as
FCF Margin | = | Free Cash Flow (Q: Mar. 2020 ) | / | Revenue (Q: Mar. 2020 ) |
= | -13.788 | / | 8.873 | |
= | -155.39 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Stemline Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Darren S Cline | director | 35 CAMBRIDGE PARK DRIVE, CAMBRIDGE MA 02140 |
Kenneth J Zuerblis | director | 20 KINGSBRIDGE RD, PISCATAWAY NJ 08854 |
Daniel Hume | director | 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK NY 10019 |
Kenneth Hoberman | officer: Chief Operating Officer | 750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10024 |
Ron Bentsur | director | 750 LEXINGTON AVE, 20TH FL, NEW YORK NY 10022 |
Alan S Forman | director | 55 WHITNEY AVENUE, 5TH FLOOR, NEW HAVEN CT 06511 |
Eric Dobmeier | director | C/O SAETTLE GENETICS INC, 21823 30TH DRIVE SE, BOTHELL WA 98021 |
J Kevin Buchi | director | 41 MOORES ROAD, FRAZER PA 19355 |
Eric K Rowinsky | officer: Chief Medical Officer | IMCLONE SYSTEMS INCORPORATED, 180 VARICK STREET, 6TH FLOOR, NEW YORK NY 10014 |
From GuruFocus
By Marketwired Marketwired • 12-07-2019
By Alberto Abaterusso Alberto Abaterusso • 04-13-2020
By Marketwired Marketwired • 05-04-2020
By Marketwired Marketwired • 11-06-2019
By Marketwired Marketwired • 09-27-2019
By PRNewswire PRNewswire • 02-04-2020
By Marketwired Marketwired • 05-21-2020
By Marketwired Marketwired • 01-09-2020
By Marketwired Marketwired • 05-19-2020
By Marketwired Marketwired • 09-27-2019
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.